CHAIRMAN
OF THE BOARD
Dr.
Gerald H. Moeller
|
 |
Dr.
Moeller has more then 25 years experience in the
HealthCare Industry.
From
1975 to 1998 he was with Boehringer Mannheim, a
leader in the Diagnostic and Biopharmaceutical
Industry. After years of functional responsibility
in Q.A., Marketing and R&D in Germany, Japan
and the U.S., he was promoted to heading various
business units, such as Decentralized Diagnostics
and Advanced Diagnostics & Biochemicals.
He
was Chief Technology Officer of the company
and CEO of Boehringer Mannheim Therapeutics before
being appointed CEO of the worldwide Boehringer
Mannheim Group, with 18,000 employees and a turnover
of approximately $4 billion in 1997. In 1998 Boehringer Mannheim was
acquired by ROCHE, Switzerland. Dr. Moeller joined
ROCHE as Head of PharmaDevelopment and Marketing
and is a member of the Executive Committee.
He
left ROCHE at the end of 1998 and since then has joined the
Board of several BioTech Companies in Germany, UK
and USA such as Pelikan Technologies, Morphosys,
Powderject Pharmaceuticals and Ferraris. Dr. Moeller is
also Chairman of 4sigma, a German HealthCare
Service provider and CEO of HBM
BioCapitalManagement, a member of the Swiss-based
HBM Group, a leading European venture capital firm
in healthcare.
|
